Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients.

被引：0
|
作者：
Puoti, M
Zanini, B
Quinizan, P
Santantonio, T
Cavaliere, R
Roldan, EQ
Castelli, F
Suter, F
Pastore, G
Carosi, G
机构：
[1] Univ Brescia, AO Spedali Civili Brescia, MaSTer HIV HCV Coinfect Study Grp, Brescia, Italy
[2] Osped Riuniti Bergamo, Div Malattie Infett, I-24100 Bergamo, Italy
[3] Univ Bari, Clin Malattie Infett, Bari, Italy
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1692
引用
下载
收藏
页码：586A / 586A
页数：1
相关论文
共 50 条
  • [41] Daily induction combination treatment with alfa2b interferon or standard combination treatment in naive chronic hepatitis C patients. A controlled multicenter randomized trail.
    Van Vlierberghe, HR
    Leroux-Roels, F
    Bourgeois, N
    Nevens, F
    Colie, I
    Henrion, J
    Delwaide, J
    Horsmans, Y
    Brenard, R
    Michielsen, P
    Robaeys, G
    Bruckers, L
    HEPATOLOGY, 2000, 32 (04) : 364A - 364A
  • [42] A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1
    Tassopoulos, NC
    Tsantoulas, D
    Raptopoulou, M
    Vassiliadis, T
    Kanatakis, S
    Paraskevas, E
    Vafiadis, I
    Avgerinos, A
    Tzathas, C
    Manolakopoulos, S
    Ketikoglou, I
    Aggelis, P
    Goritsas, K
    Giannoulis, G
    G, GH
    Thomopoulos, K
    Akriviadis, E
    Sypsa, V
    Hatzakis, A
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (03) : 189 - 196
  • [43] A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response
    Shiffman, ML
    Hofmann, CM
    Sterling, RK
    Luketic, VA
    Contos, MJ
    Sanyal, AJ
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (04): : 405 - 409
  • [44] Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study
    Acharya, Subrat K.
    Sreenivas, V.
    Gupta, Siddharth Datta
    Kumar, Shakti
    Chawla, Yogesh K.
    Tandon, Anurag
    Habeeb, Aejaz
    Kar, Premashish
    Chowdhury, Abhijit
    Choudhuri, Gourdas
    Sarin, Shiv K.
    Amarapurkar, D. N.
    Arankalle, Vidya
    Gupte, Mohan D.
    Gupta, Sushma
    Mukherjee, Deepali
    Seth, Divya
    Goyal, Rohit
    Tandon, Badri N.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (01) : 10 - 18
  • [45] Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
    Murphy, Alison A.
    Herrmann, Eva
    Osinusi, Anu O.
    Wu, Lynn
    Sachau, William
    Lempicki, Richard A.
    Yang, Jun
    Chung, Tei L.
    Wood, Brad J.
    Haagmans, Bart L.
    Kottilil, Shyam
    Polis, Michael A.
    AIDS, 2011, 25 (09) : 1179 - 1187
  • [46] Efficacy of daily interferon-alpha-2b (IFN-A) in combination with ribavirin in the treatment of naive patients with chronic hepatitis C (CHC): A randomised controlled trail.
    Tassopoulos, NC
    Raptopoulou, M
    Ketikoglou, I
    Paraskevas, E
    Kanatakis, S
    Tsantoulas, D
    Vafiadis, I
    Hatzis, G
    Kouroumalis, E
    Sidiropoulos, L
    Sypsa, V
    Hatzakis, A
    HEPATOLOGY, 2000, 32 (04) : 365A - 365A
  • [47] Final results of ANRS HC02-RIBAVIC: A randomized controlled trial of pegylated-interferon alfa-2B plus ribavirin vs interferon alfa-2B plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected
    Pol, S
    Carrat, F
    Bani-Sadr, F
    Rosenthal, E
    Lunel, F
    Morand, P
    Salmon, D
    Pialoux, G
    Patrice, C
    Christian, P
    HEPATOLOGY, 2004, 40 (04) : 315A - 315A
  • [48] Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients
    Rockstroh, JK
    Mudar, M
    Lichterfeld, M
    Nischalke, HD
    Klausen, G
    Gölz, J
    Dupke, S
    Notheis, G
    Stein, L
    Mauss, S
    AIDS, 2002, 16 (15) : 2083 - 2085
  • [49] Daily administration of interferon alpha 2B and utility of combination therapy with ribavirin as initial treatment for chronic hepatitis C: Follow up of patients.
    Ricchiuti, A
    Ciccorossi, P
    Costa, F
    Bellini, M
    Carrara, PD
    Arpe, P
    Petruccelli, S
    Maggi, F
    Vatteroni, ML
    Bendinelli, M
    Maltinti, G
    Marchi, S
    HEPATOLOGY, 2000, 32 (04) : 366A - 366A
  • [50] Randomized, controlled trial with interferon-alpha (IFN-alpha) combined with ribavirin with and without amantadine sulfate in primary IFN-alpha nonresponsive patients with chronic hepatitis C
    Teuber, G
    Berg, T
    Lafrenz, M
    Weidenbach, H
    Schoelmerich, J
    Wietzke-Braun, P
    Pausch, J
    Arnold, R
    Lock, G
    Hopf, U
    Zeuzem, S
    JOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23
12345